Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BLLN

Billiontoone Inc

Feb 06 • 04:00PM ET

90.61

+5.46 6.41 %

Healthcare • Diagnostics & Research • USA • NASD

Held by: VTI VB VXF VBR VBK SCHA ITOT LFSC ONEQ TMSL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.32	Insider Own	54.28%	Shs Outstand	41.22M	Perf Week	9.82%
Market Cap	4.15B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	20.93M	Perf Month	1.31%
Enterprise Value	4.48B	PEG	-	EPS next Q	0.06	Inst Own	4.05%	Short Float	3.40%	Perf Quarter	-
Income	-14.20M	P/S	16.32	EPS this Y	-	Inst Trans	14.11%	Short Ratio	3.02	Perf Half Y	-
Sales	254.14M	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.71M	Perf YTD	10.72%
Book/sh	-5.23	P/C	21.25	EPS next 5Y	-	ROE	-	52W High	138.70 -34.67%	Perf Year	-
Cash/sh	4.26	P/FCF	-	EPS past 3/5Y	- -	ROIC	-5.03%	52W Low	80.00 13.26%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	1956.12	Sales past 3/5Y	- -	Gross Margin	65.15%	Volatility	5.22% 7.25%	Perf 5Y	-
Dividend TTM	-	EV/Sales	17.63	EPS Y/Y TTM	-	Oper. Margin	-2.36%	ATR (14)	6.42	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.75	Sales Y/Y TTM	-	Profit Margin	-5.59%	RSI (14)	52.54	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	6.17	EPS Q/Q	109.87%	SMA20	3.26%	Beta	-	Target Price	135.29
Payout	-	Debt/Eq	0.60	Sales Q/Q	117.40%	SMA50	-4.67%	Rel Volume	0.43	Prev Close	85.15
Employees	-	LT Debt/Eq	0.57	Earnings	Dec 09 AMC	SMA200	-5.87%	Avg Volume	236.09K	Price	90.61
IPO	Nov 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	-28.32% 0.72%	Trades		Volume	100,834	Change	6.41%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-26	Initiated	Guggenheim	Buy	$120
Dec-01-25	Initiated	William Blair	Outperform
Dec-01-25	Initiated	Wells Fargo	Equal Weight	$110
Dec-01-25	Initiated	Stifel	Buy	$145
Dec-01-25	Initiated	Piper Sandler	Overweight	$150
Dec-01-25	Initiated	JP Morgan	Overweight	$150
Dec-01-25	Initiated	Jefferies	Hold	$117
Dec-01-25	Initiated	BTIG Research	Buy	$160

Jan-23-26 10:23AM	Class of 2025 IPOs: 3 Stocks With Bullish Charts (Barrons.com)
Jan-15-26 08:58AM	BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare (PR Newswire)
Jan-13-26 09:43AM	What's Going On With BillionToOne Shares Tuesday? (Benzinga)
04:24AM	BillionToOne Showcases Single-Molecule NGS at JPMorgan, Lifts 202526 Revenue Outlook (MarketBeat)
Jan-12-26 08:05AM	BillionToOne Provides Guidance for 2026 (GlobeNewswire) +15.37%
09:00AM	Loading…
Jan-06-26 09:00AM	BillionToOne Announces Selection of Northstar Select as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East (PR Newswire)
Jan-01-26 12:13AM	2 New IPO Stocks Enter the Fray; J.P. Morgan Says Buy (TipRanks)
Dec-23-25 08:05AM	BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -9.57%
Dec-09-25 04:07PM	BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair (PR Newswire) -5.32%
04:05PM	BillionToOne Reports Third Quarter 2025 Results (GlobeNewswire)
07:10AM	Medline seeks $5.37bn in largest healthcare IPO of 2025 (Medical Device Network)
Dec-03-25 04:00PM	AppLovin Stock Rides Swarm Of Setups Beyond Just Mining, Medical Names (Investor's Business Daily) -10.58%
Dec-02-25 08:05AM	BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 (GlobeNewswire)
Dec-01-25 12:16PM	BillionToOne wins bullish backing, but Jefferies and Wells Fargo urge caution (Investing.com) -13.17%
09:46AM	Carvana initiated, Zscaler downgraded: Wall Street's top analyst calls (The Fly)
12:59PM	Loading…
Nov-26-25 12:59PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily)
Nov-25-25 05:00PM	IPO Stock Taps Massive Medicare Market, Soars Into Buy Range (Investor's Business Daily) +8.32%
Nov-18-25 12:34AM	Jim Cramer Says BillionToOne Has a "Fantastic Story" Within the Diagnostics Space (Insider Monkey) +6.41%
Nov-07-25 04:05PM	BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) -8.18%
Nov-06-25 05:02PM	Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering (PR Newswire)
03:39PM	What Shutdown? The IPO Window Is Still Open for Some Companies (Barrons.com)
Nov-05-25 09:53PM	BillionToOne Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. BillionToOne was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BLLN

Billiontoone Inc

Upgrade your FINVIZ experience